You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 593 Efficacy of invariant natural killer T cell infusion plus transarterial embolization vs transarterial embolization alone for hepatocellular carcinoma patients: a phase 2 randomized clinical trial

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trial Completed
593 Efficacy of invariant natural killer T cell infusion plus transarterial embolization vs transarterial embolization alone for hepatocellular carcinoma patients: a phase 2 randomized clinical trial

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023174012
Dec 202383011
Jan 20243401
Feb 202411202
Mar 20242805
Apr 20245003
May 20242200
Jun 20241600
Jul 20241601
Aug 20241404
Sep 20241402
Oct 20243404
Nov 20242003
Dec 20241206
Jan 20253409
Feb 2025404
Mar 2025004
Apr 2025006
May 2025006
Jun 2025004
Total667087